Vimarsana
Biggest News Aggregation in the World

Asthma Quality News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Asthma Quality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Asthma Quality Today - Breaking & Trending Today

Despite High Asthma Biologics Response Rate, Severe Disease Control Is Lacking - Vimarsana News

Despite High Asthma Biologics Response Rate, Severe Disease Control Is Lacking

Asthma biologic response is high in patients with severe asthma, yet few of these patients have their severe disease under control.

Biologics' Efficacy in Severe, Uncontrolled Asthma Associated With Higher Blood Eosinophil Count - Vimarsana News

Biologics' Efficacy in Severe, Uncontrolled Asthma Associated With Higher Blood Eosinophil Count

Higher baseline blood eosinophil count was linked to improvement in asthma exacerbations and overall better outcomes seen with biologic therapies.

Source: ajmc.com
Male, female patients experience similar asthma improvements with tezepelumab - Vimarsana News

Male, female patients experience similar asthma improvements with tezepelumab

WASHINGTON — Male and female patients experienced similar improvements in their severe, uncontrolled asthma with tezepelumab over a 52-week period, according to data presented at the American Thoracic Society International Conference.“Sex-related differences in asthma prevalence and severity are well documented,” Monica Kraft, MD, Murray M. Rosenberg Professor of Medicine and

Source: healio.com
Bronchial Thermoplasty Matches Biologics for Severe Asthma - Vimarsana News

Bronchial Thermoplasty Matches Biologics for Severe Asthma

Adults with severe asthma showed similar improvements in symptoms and quality of life after treatment with BT as compared with biologics.

Tezepelumab Significantly Benefits Severe Asthma Regardless of Patient Sex - Vimarsana News

Tezepelumab Significantly Benefits Severe Asthma Regardless of Patient Sex

An analysis of the phase 3 NAVIGATOR trial shows tezepelumab did not provide differing efficacy among men and women, despite historic trends of disparate severe asthma outcomes among sexes.